|
G |
G6PC1 |
glucose-6-phosphatase catalytic subunit 1 |
increases expression multiple interactions |
EXP |
dihydroouabain results in increased expression of G6PC1 mRNA dihydroouabain promotes the reaction [RORC protein binds to G6PC1 promoter] |
CTD |
PMID:29981919 |
|
NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
|
|
G |
IL17A |
interleukin 17A |
multiple interactions |
EXP |
dihydroouabain results in increased expression of and results in increased secretion of IL17A protein |
CTD |
PMID:29981919 |
|
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL17F |
interleukin 17F |
multiple interactions |
EXP |
dihydroouabain results in increased expression of and results in increased secretion of IL17F protein |
CTD |
PMID:29981919 |
|
NCBI chr 6:52,236,681...52,245,689
Ensembl chr 6:52,236,681...52,245,689
|
|
G |
NPAS2 |
neuronal PAS domain protein 2 |
multiple interactions increases expression |
EXP |
dihydroouabain promotes the reaction [RORC protein binds to NPAS2 promoter] dihydroouabain results in increased expression of NPAS2 mRNA |
CTD |
PMID:29981919 |
|
NCBI chr 2:100,818,723...100,996,829
Ensembl chr 2:100,820,139...100,996,829
|
|
G |
RORC |
RAR related orphan receptor C |
multiple interactions increases expression |
EXP |
dihydroouabain promotes the reaction [RORC protein binds to G6PC1 promoter]; dihydroouabain promotes the reaction [RORC protein binds to NPAS2 promoter]; RORC protein promotes the reaction [dihydroouabain results in increased expression of RORC mRNA] |
CTD |
PMID:29981919 |
|
NCBI chr 1:151,806,071...151,831,802
Ensembl chr 1:151,806,071...151,831,845
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
multiple interactions |
EXP |
Fusidic Acid inhibits the reaction [ABCB1 protein results in increased export of Digoxin] |
CTD |
PMID:26888941 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCB11 |
ATP binding cassette subfamily B member 11 |
decreases activity multiple interactions |
ISO EXP |
Fusidic Acid results in decreased activity of ABCB11 protein Fusidic Acid inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] |
CTD |
PMID:12106615 PMID:20829430 PMID:23956101 PMID:24014644 PMID:27676153 |
|
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
ISO |
Fusidic Acid results in decreased expression of and results in decreased activity of ABCC2 protein |
CTD |
PMID:12106615 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
multiple interactions |
EXP |
Fusidic Acid inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam] |
CTD |
PMID:26888941 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
SLC10A1 |
solute carrier family 10 member 1 |
multiple interactions |
EXP |
Fusidic Acid inhibits the reaction [SLC10A1 protein results in increased transport of Taurocholic Acid] |
CTD |
PMID:27676153 |
|
NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
|
|
G |
SLCO1A2 |
solute carrier organic anion transporter family member 1A2 |
multiple interactions |
ISO |
Fusidic Acid inhibits the reaction [SLCO1A4 protein results in increased uptake of Rosuvastatin Calcium] |
CTD |
PMID:26888941 |
|
NCBI chr12:21,264,600...21,419,634
Ensembl chr12:21,264,600...21,419,594
|
|
G |
SLCO1B1 |
solute carrier organic anion transporter family member 1B1 |
decreases activity multiple interactions |
EXP |
Fusidic Acid results in decreased activity of SLCO1B1 protein Fusidic Acid inhibits the reaction [SLCO1B1 protein results in increased uptake of Rosuvastatin Calcium] |
CTD |
PMID:26888941 PMID:27676153 |
|
NCBI chr12:21,131,194...21,239,796
Ensembl chr12:21,131,194...21,239,796
|
|
G |
SLCO1B3 |
solute carrier organic anion transporter family member 1B3 |
multiple interactions decreases activity |
EXP ISO |
Fusidic Acid inhibits the reaction [SLCO1B3 protein results in increased uptake of Rosuvastatin Calcium] Fusidic Acid inhibits the reaction [SLCO1B2 protein results in increased uptake of Rosuvastatin Calcium] Fusidic Acid results in decreased activity of SLCO1B3 protein |
CTD |
PMID:26888941 PMID:27676153 |
|
NCBI chr12:20,810,705...20,916,911
Ensembl chr12:20,810,702...20,916,911
|
|
G |
UGT1A1 |
UDP glucuronosyltransferase family 1 member A1 |
multiple interactions |
EXP |
Fusidic Acid inhibits the reaction [UGT1A1 protein results in increased glucuronidation of Estradiol] |
CTD |
PMID:27676153 |
|
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
|
|
|
G |
A2M |
alpha-2-macroglobulin |
affects expression |
EXP |
Ouabain affects the expression of A2M protein |
CTD |
PMID:17268060 |
|
NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
multiple interactions increases expression |
EXP |
2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [Ouabain results in increased expression of ABCB1 protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Ouabain results in increased expression of ABCB1 mRNA]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Ouabain results in increased expression of ABCB1 protein]; [Ouabain results in increased expression of ABCB1] which results in decreased susceptibility to Doxorubicin; KN 93 inhibits the reaction [Ouabain results in increased expression of ABCB1 protein] Ouabain results in increased expression of ABCB1 mRNA; Ouabain results in increased expression of ABCB1 protein |
CTD |
PMID:19647009 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ACAA2 |
acetyl-CoA acyltransferase 2 |
affects expression |
EXP |
Ouabain affects the expression of ACAA2 protein |
CTD |
PMID:17268060 |
|
NCBI chr18:49,782,164...49,813,533
Ensembl chr18:49,782,164...49,813,953
|
|
G |
ACE |
angiotensin I converting enzyme |
affects expression |
ISO |
Ouabain affects the expression of ACE mRNA; Ouabain affects the expression of ACE protein |
CTD |
PMID:16565308 |
|
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
|
|
G |
ACTA2 |
actin alpha 2, smooth muscle |
affects expression |
EXP |
Ouabain affects the expression of ACTA2 protein |
CTD |
PMID:17268060 |
|
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,935,074...88,991,339
|
|
G |
ADH1C |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
affects expression |
EXP |
Ouabain affects the expression of ADH1C protein |
CTD |
PMID:17268060 |
|
NCBI chr 4:99,336,497...99,352,746
Ensembl chr 4:99,336,497...99,352,746
|
|
G |
AGT |
angiotensinogen |
affects expression increases expression |
ISO |
Ouabain affects the expression of AGT protein Ouabain results in increased expression of AGT protein |
CTD |
PMID:11768735 PMID:16565308 |
|
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
|
|
G |
AGTR1 |
angiotensin II receptor type 1 |
affects expression decreases expression |
ISO |
Ouabain affects the expression of AGTR1A mRNA Ouabain results in decreased expression of AGTR1A protein |
CTD |
PMID:16565308 |
|
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
|
|
G |
AIFM1 |
apoptosis inducing factor mitochondria associated 1 |
increases expression |
EXP |
Ouabain results in increased expression of AIFM1 protein |
CTD |
PMID:31436044 |
|
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
|
|
G |
ANXA1 |
annexin A1 |
affects expression |
EXP |
Ouabain affects the expression of ANXA1 protein |
CTD |
PMID:17268060 |
|
NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,393
|
|
G |
ANXA2 |
annexin A2 |
affects expression |
EXP |
Ouabain affects the expression of ANXA2 protein |
CTD |
PMID:17268060 |
|
NCBI chr15:60,347,151...60,397,986
Ensembl chr15:60,347,134...60,402,883
|
|
G |
APAF1 |
apoptotic peptidase activating factor 1 |
increases expression |
EXP |
Ouabain results in increased expression of APAF1 protein |
CTD |
PMID:31436044 |
|
NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,290...98,735,433
|
|
G |
ARAF |
A-Raf proto-oncogene, serine/threonine kinase |
decreases expression |
EXP |
Ouabain results in decreased expression of ARAF mRNA |
CTD |
PMID:16412265 |
|
NCBI chr X:47,561,205...47,571,908
Ensembl chr X:47,561,205...47,571,908
|
|
G |
ARIH1 |
ariadne RBR E3 ubiquitin protein ligase 1 |
decreases expression |
EXP |
Ouabain results in decreased expression of ARIH1 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr15:72,474,330...72,602,987
Ensembl chr15:72,474,330...72,602,987
|
|
G |
ARPC5 |
actin related protein 2/3 complex subunit 5 |
affects expression |
EXP |
Ouabain affects the expression of ARPC5 protein |
CTD |
PMID:17268060 |
|
NCBI chr 1:183,620,846...183,635,783
Ensembl chr 1:183,620,846...183,635,783
|
|
G |
ARRB1 |
arrestin beta 1 |
increases expression |
EXP |
Ouabain results in increased expression of ARRB1 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr11:75,260,122...75,351,661
Ensembl chr11:75,260,122...75,351,705
|
|
G |
ASAH1 |
N-acylsphingosine amidohydrolase 1 |
affects expression |
EXP |
Ouabain affects the expression of ASAH1 protein |
CTD |
PMID:17268060 |
|
NCBI chr 8:18,055,992...18,084,961
Ensembl chr 8:18,055,992...18,084,998
|
|
G |
ATF6B |
activating transcription factor 6 beta |
increases expression |
EXP |
Ouabain results in increased expression of ATF6B protein |
CTD |
PMID:31436044 |
|
NCBI chr 6:32,115,264...32,128,246
Ensembl chr 6:32,115,264...32,128,253
|
|
G |
ATM |
ATM serine/threonine kinase |
increases phosphorylation |
EXP |
Ouabain results in increased phosphorylation of ATM protein |
CTD |
PMID:31436044 |
|
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,823...108,369,102
|
|
G |
ATP12A |
ATPase H+/K+ transporting non-gastric alpha2 subunit |
multiple interactions |
EXP |
Ouabain inhibits the reaction [[ATP12A protein co-treated with ATP4B protein] results in increased uptake of Rubidium] |
CTD |
PMID:8853415 |
|
NCBI chr13:24,680,408...24,712,472
Ensembl chr13:24,680,408...24,712,472
|
|
G |
ATP1A1 |
ATPase Na+/K+ transporting subunit alpha 1 |
multiple interactions increases expression affects expression affects binding |
EXP ISO |
Lithium inhibits the reaction [Ouabain results in increased expression of ATP1A1 mRNA]; Lithium inhibits the reaction [Ouabain results in increased expression of ATP1A1 protein] Ouabain affects the expression of ATP1A1 protein Ouabain results in increased expression of ATP1A1 mRNA; Ouabain results in increased expression of ATP1A1 protein Ouabain binds to ATP1A1 protein |
CTD |
PMID:11768735 PMID:11834625 PMID:12479229 PMID:16716361 PMID:19995221 |
|
NCBI chr 1:116,373,244...116,404,774
Ensembl chr 1:116,372,668...116,410,261
|
|
G |
ATP1A2 |
ATPase Na+/K+ transporting subunit alpha 2 |
multiple interactions increases expression decreases expression affects expression decreases activity affects response to substance affects binding |
EXP ISO |
Lithium inhibits the reaction [Ouabain results in increased expression of ATP1A2 mRNA] Ouabain results in increased expression of ATP1A2 protein Ouabain results in decreased expression of ATP1A2 mRNA Ouabain affects the expression of ATP1A2 protein N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in decreased expression of ATP1A2 mRNA] Ouabain results in decreased activity of ATP1A2 protein Ouabain binds to and results in decreased activity of ATP1A2 protein ATP1A2 protein affects the susceptibility to Ouabain Ouabain binds to ATP1A2 protein |
CTD |
PMID:11834625 PMID:12479229 PMID:15458945 PMID:16166162 PMID:16716361 PMID:18487447 PMID:19687166 PMID:19897708 PMID:19995221 More...
|
|
NCBI chr 1:160,115,759...160,143,591
Ensembl chr 1:160,115,759...160,143,591
|
|
G |
ATP1A3 |
ATPase Na+/K+ transporting subunit alpha 3 |
increases expression multiple interactions decreases expression affects expression affects binding |
EXP ISO |
Ouabain results in increased expression of ATP1A3 mRNA; Ouabain results in increased expression of ATP1A3 protein Potassium Chloride inhibits the reaction [ATP1A3 protein binds to Ouabain] Ouabain results in decreased expression of ATP1A3 mRNA Ouabain affects the expression of ATP1A3 protein N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in decreased expression of ATP1A3 mRNA] ATP1A3 protein binds to Ouabain; Ouabain binds to ATP1A3 protein |
CTD |
PMID:11204457 PMID:12479229 PMID:15276875 PMID:19687166 PMID:19995221 PMID:24631656 More...
|
|
NCBI chr19:41,966,582...41,994,230
Ensembl chr19:41,966,582...41,997,497
|
|
G |
ATP1B1 |
ATPase Na+/K+ transporting subunit beta 1 |
multiple interactions increases expression |
ISO |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Ouabain results in increased expression of ATP1B1 mRNA]; Calcium affects the reaction [Ouabain results in increased expression of ATP1B1 mRNA]; W 7 inhibits the reaction [Ouabain results in increased expression of ATP1B1 mRNA] |
CTD |
PMID:11204457 |
|
NCBI chr 1:169,106,690...169,132,719
Ensembl chr 1:169,105,697...169,310,992
|
|
G |
ATP4B |
ATPase H+/K+ transporting subunit beta |
multiple interactions |
EXP |
Ouabain inhibits the reaction [[ATP12A protein co-treated with ATP4B protein] results in increased uptake of Rubidium] |
CTD |
PMID:8853415 |
|
NCBI chr13:113,648,804...113,658,198
Ensembl chr13:113,648,804...113,658,198
|
|
G |
ATP5F1A |
ATP synthase F1 subunit alpha |
affects expression |
EXP |
Ouabain affects the expression of ATP5F1A protein |
CTD |
PMID:17268060 |
|
NCBI chr18:46,080,248...46,104,227
Ensembl chr18:46,080,248...46,104,334
|
|
G |
ATR |
ATR serine/threonine kinase |
decreases phosphorylation |
EXP |
Ouabain results in decreased phosphorylation of ATR protein |
CTD |
PMID:31436044 |
|
NCBI chr 3:142,449,235...142,578,733
Ensembl chr 3:142,449,007...142,578,733
|
|
G |
BAHD1 |
bromo adjacent homology domain containing 1 |
decreases expression |
EXP |
Ouabain results in decreased expression of BAHD1 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr15:40,437,452...40,468,236
Ensembl chr15:40,439,721...40,468,236
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
affects localization increases expression multiple interactions |
EXP |
Ouabain affects the localization of BAX protein Ouabain results in increased expression of BAX protein Ouabain inhibits the reaction [HSPD1 protein binds to BAX protein] |
CTD |
PMID:17096883 PMID:18247327 PMID:31436044 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
decreases expression |
EXP |
Ouabain results in decreased expression of BCL2 protein |
CTD |
PMID:31436044 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
decreases expression |
EXP |
Ouabain results in decreased expression of BCL2L1 protein |
CTD |
PMID:31436044 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BDNF |
brain derived neurotrophic factor |
multiple interactions decreases expression |
ISO |
Lithium inhibits the reaction [Ouabain results in decreased expression of BDNF protein] |
CTD |
PMID:19954800 |
|
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
|
|
G |
BRCA1 |
BRCA1 DNA repair associated |
decreases expression |
EXP |
Ouabain results in decreased expression of BRCA1 protein |
CTD |
PMID:31436044 |
|
NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245
|
|
G |
CALB1 |
calbindin 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of CALB1 protein |
CTD |
PMID:20105455 |
|
NCBI chr 8:90,058,608...90,082,879
Ensembl chr 8:90,058,608...90,095,475
|
|
G |
CALML5 |
calmodulin like 5 |
affects expression |
EXP |
Ouabain affects the expression of CALML5 protein |
CTD |
PMID:17268060 |
|
NCBI chr10:5,498,697...5,499,570
Ensembl chr10:5,498,697...5,499,570
|
|
G |
CAMK2B |
calcium/calmodulin dependent protein kinase II beta |
increases expression |
EXP |
Ouabain results in increased expression of CAMK2B protein |
CTD |
PMID:31436044 |
|
NCBI chr 7:44,217,154...44,326,013
Ensembl chr 7:44,210,019...44,334,577
|
|
G |
CANX |
calnexin |
increases expression |
EXP |
Ouabain results in increased expression of CANX protein |
CTD |
PMID:18247327 |
|
NCBI chr 5:179,678,656...179,731,641
Ensembl chr 5:179,678,628...179,731,641
|
|
G |
CASP3 |
caspase 3 |
increases expression multiple interactions increases activity |
EXP ISO |
Ouabain results in increased expression of CASP3 protein Ouabain results in increased activity of and results in increased cleavage of CASP3 protein Ouabain results in increased activity of CASP3 protein |
CTD |
PMID:11435898 PMID:17096883 PMID:18247327 PMID:20435043 PMID:31436044 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP4 |
caspase 4 |
increases expression |
EXP |
Ouabain results in increased expression of CASP4 protein |
CTD |
PMID:31436044 |
|
NCBI chr11:104,942,866...104,968,574
Ensembl chr11:104,942,866...104,969,366
|
|
G |
CASP8 |
caspase 8 |
multiple interactions |
EXP |
Ouabain results in increased expression of and results in increased activity of CASP8 protein |
CTD |
PMID:31436044 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
multiple interactions |
EXP |
Ouabain results in increased expression of and results in increased activity of CASP9 protein |
CTD |
PMID:31436044 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions decreases activity |
ISO |
Lithium inhibits the reaction [Ouabain results in decreased activity of CAT protein]; Valproic Acid inhibits the reaction [Ouabain results in decreased activity of CAT protein] |
CTD |
PMID:20627318 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CAV1 |
caveolin 1 |
decreases expression |
EXP |
Ouabain results in decreased expression of CAV1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 7:116,525,009...116,561,185
Ensembl chr 7:116,524,994...116,561,179
|
|
G |
CCDC14 |
coiled-coil domain containing 14 |
decreases expression |
EXP |
Ouabain results in decreased expression of CCDC14 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 3:123,885,176...123,961,229
Ensembl chr 3:123,897,305...123,961,408
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions increases expression |
ISO |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Ouabain results in increased expression of CCL2 mRNA]; Amiloride inhibits the reaction [Ouabain results in increased expression of CCL2 protein]; Sodium deficiency inhibits the reaction [Ouabain results in increased expression of CCL2 mRNA]; Sodium deficiency inhibits the reaction [Ouabain results in increased expression of CCL2 protein] Ouabain results in increased expression of CCL2 mRNA; Ouabain results in increased expression of CCL2 protein |
CTD |
PMID:11340305 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCNA1 |
cyclin A1 |
decreases expression |
EXP |
Ouabain results in decreased expression of CCNA1 mRNA |
CTD |
PMID:20460749 |
|
NCBI chr13:36,431,517...36,442,870
Ensembl chr13:36,431,520...36,442,870
|
|
G |
CCNA2 |
cyclin A2 |
decreases expression |
EXP |
Ouabain results in decreased expression of CCNA2 mRNA |
CTD |
PMID:21215801 |
|
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
|
|
G |
CCND1 |
cyclin D1 |
decreases expression |
EXP |
Ouabain results in decreased expression of CCND1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CDH1 |
cadherin 1 |
increases expression decreases expression |
EXP |
Ouabain results in increased expression of CDH1 mRNA Ouabain results in decreased expression of CDH1 protein |
CTD |
PMID:28795476 |
|
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
|
|
G |
CDH2 |
cadherin 2 |
decreases expression |
EXP |
Ouabain results in decreased expression of CDH2 mRNA; Ouabain results in decreased expression of CDH2 protein |
CTD |
PMID:28795476 |
|
NCBI chr18:27,932,879...28,177,130
Ensembl chr18:27,932,879...28,177,946
|
|
G |
CDK2 |
cyclin dependent kinase 2 |
decreases expression |
EXP |
Ouabain results in decreased expression of CDK2 mRNA; Ouabain results in decreased expression of CDK2 protein |
CTD |
PMID:20460749 PMID:21215801 PMID:31436044 |
|
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
|
|
G |
CDK6 |
cyclin dependent kinase 6 |
decreases expression |
EXP |
Ouabain results in decreased expression of CDK6 protein |
CTD |
PMID:31436044 |
|
NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,573
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
decreases expression increases expression |
EXP |
Ouabain results in decreased expression of CDKN1A mRNA; Ouabain results in decreased expression of CDKN1A protein Ouabain results in increased expression of CDKN1A mRNA; Ouabain results in increased expression of CDKN1A protein |
CTD |
PMID:20460749 PMID:21215801 PMID:28795476 PMID:31436044 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
|
|
G |
CKB |
creatine kinase B |
decreases activity |
ISO |
Ouabain results in decreased activity of CKB protein |
CTD |
PMID:19911114 |
|
NCBI chr14:103,519,667...103,522,830
Ensembl chr14:103,519,667...103,522,833
|
|
G |
CLDN1 |
claudin 1 |
decreases expression |
EXP |
Ouabain results in decreased expression of CLDN1 protein |
CTD |
PMID:18247327 |
|
NCBI chr 3:190,305,707...190,322,446
Ensembl chr 3:190,305,707...190,322,446
|
|
G |
CNPY2 |
canopy FGF signaling regulator 2 |
affects expression |
EXP |
Ouabain affects the expression of CNPY2 protein |
CTD |
PMID:17268060 |
|
NCBI chr12:56,309,844...56,316,346
Ensembl chr12:56,309,842...56,316,119
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
increases expression multiple interactions |
ISO |
Ouabain results in increased expression of COL1A1 mRNA MIR29B1 mRNA inhibits the reaction [Ouabain results in increased expression of COL1A1 mRNA] |
CTD |
PMID:26702050 |
|
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
CS |
citrate synthase |
decreases activity |
ISO |
Ouabain results in decreased activity of CS protein |
CTD |
PMID:20372980 |
|
NCBI chr12:56,271,699...56,300,330
Ensembl chr12:56,271,699...56,300,391
|
|
G |
CYC1 |
cytochrome c1 |
multiple interactions |
EXP |
Ouabain results in decreased expression of and affects the localization of CYC1 protein |
CTD |
PMID:18247327 |
|
NCBI chr 8:144,095,076...144,097,525
Ensembl chr 8:144,095,039...144,097,525
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
increases expression |
EXP |
Ouabain results in increased expression of DDIT3 protein |
CTD |
PMID:31436044 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
DDOST |
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit |
decreases expression |
EXP |
Ouabain results in decreased expression of DDOST mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 1:20,651,777...20,661,369
Ensembl chr 1:20,651,767...20,661,544
|
|
G |
DNAJA3 |
DnaJ heat shock protein family (Hsp40) member A3 |
increases expression |
EXP |
Ouabain results in increased expression of DNAJA3 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr16:4,425,868...4,456,775
Ensembl chr16:4,425,805...4,456,775
|
|
G |
DRD1 |
dopamine receptor D1 |
multiple interactions decreases expression |
EXP ISO |
Ouabain results in decreased expression of and results in increased phosphorylation of DRD1 protein Ouabain results in increased phosphorylation of and results in decreased expression of DRD1 protein Ouabain results in decreased expression of DRD1 mRNA |
CTD |
PMID:19626329 PMID:20132239 |
|
NCBI chr 5:175,440,036...175,444,182
Ensembl chr 5:175,440,036...175,444,182
|
|
G |
DSG1 |
desmoglein 1 |
affects expression |
EXP |
Ouabain affects the expression of DSG1 protein |
CTD |
PMID:17268060 |
|
NCBI chr18:31,318,160...31,359,246
Ensembl chr18:31,318,160...31,359,246
|
|
G |
DUT |
deoxyuridine triphosphatase |
affects expression |
EXP |
Ouabain affects the expression of DUT protein |
CTD |
PMID:17268060 |
|
NCBI chr15:48,331,095...48,343,373
Ensembl chr15:48,331,011...48,343,373
|
|
G |
ECE1 |
endothelin converting enzyme 1 |
increases expression |
EXP |
Ouabain results in increased expression of ECE1 protein |
CTD |
PMID:18247327 |
|
NCBI chr 1:21,217,250...21,345,504
Ensembl chr 1:21,217,247...21,345,572
|
|
G |
ECHS1 |
enoyl-CoA hydratase, short chain 1 |
affects expression |
EXP |
Ouabain affects the expression of ECHS1 protein |
CTD |
PMID:17268060 |
|
NCBI chr10:133,362,485...133,373,354
Ensembl chr10:133,362,485...133,373,354
|
|
G |
EDN1 |
endothelin 1 |
increases expression decreases expression |
ISO EXP |
Ouabain results in increased expression of EDN1 mRNA Ouabain results in decreased expression of EDN1 mRNA |
CTD |
PMID:15477225 PMID:28795476 |
|
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
EDNRA |
endothelin receptor type A |
increases expression |
ISO |
Ouabain results in increased expression of EDNRA mRNA; Ouabain results in increased expression of EDNRA protein |
CTD |
PMID:15477225 PMID:16982439 |
|
NCBI chr 4:147,481,097...147,544,954
Ensembl chr 4:147,480,917...147,544,954
|
|
G |
EGFR |
epidermal growth factor receptor |
decreases phosphorylation |
EXP |
Ouabain results in decreased phosphorylation of EGFR protein |
CTD |
PMID:28795476 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EIF2A |
eukaryotic translation initiation factor 2A |
increases expression |
EXP |
Ouabain results in increased expression of EIF2A protein |
CTD |
PMID:31436044 |
|
NCBI chr 3:150,546,787...150,586,016
Ensembl chr 3:150,546,678...150,586,016
|
|
G |
EIF2AK3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions |
EXP |
Ouabain results in increased expression of and results in increased phosphorylation of EIF2AK3 protein |
CTD |
PMID:31436044 |
|
NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518
|
|
G |
EIF3K |
eukaryotic translation initiation factor 3 subunit K |
affects expression |
EXP |
Ouabain affects the expression of EIF3K protein |
CTD |
PMID:17268060 |
|
NCBI chr19:38,619,188...38,636,954
Ensembl chr19:38,619,082...38,636,955
|
|
G |
ENDOG |
endonuclease G |
increases expression |
EXP |
Ouabain results in increased expression of ENDOG protein |
CTD |
PMID:31436044 |
|
NCBI chr 9:128,818,500...128,822,676
Ensembl chr 9:128,818,500...128,822,676
|
|
G |
ERCC4 |
ERCC excision repair 4, endonuclease catalytic subunit |
decreases expression |
EXP |
Ouabain results in decreased expression of ERCC4 mRNA |
CTD |
PMID:24124520 |
|
NCBI chr16:13,920,154...13,952,348
Ensembl chr16:13,920,138...13,952,348
|
|
G |
ETS1 |
ETS proto-oncogene 1, transcription factor |
decreases expression |
EXP |
Ouabain results in decreased expression of ETS1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr11:128,458,765...128,587,558
Ensembl chr11:128,458,761...128,587,558
|
|
G |
FADD |
Fas associated via death domain |
increases expression |
EXP |
Ouabain results in increased expression of FADD protein |
CTD |
PMID:31436044 |
|
NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,296...70,207,390
|
|
G |
FANCD2 |
FA complementation group D2 |
multiple interactions decreases expression |
EXP |
Ouabain inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein]; SB 203580 inhibits the reaction [Ouabain inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein]] Ouabain results in decreased expression of FANCD2 mRNA |
CTD |
PMID:24124520 |
|
NCBI chr 3:10,026,437...10,101,932
Ensembl chr 3:10,026,370...10,101,932
|
|
G |
FANCF |
FA complementation group F |
decreases expression |
EXP |
Ouabain results in decreased expression of FANCF mRNA |
CTD |
PMID:24124520 |
|
NCBI chr11:22,622,533...22,625,823
Ensembl chr11:22,622,533...22,625,823
|
|
G |
FANCI |
FA complementation group I |
decreases expression multiple interactions |
EXP |
Ouabain results in decreased expression of FANCI mRNA Ouabain inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCI protein] |
CTD |
PMID:24124520 |
|
NCBI chr15:89,243,979...89,317,259
Ensembl chr15:89,243,945...89,317,261
|
|
G |
FARS2 |
phenylalanyl-tRNA synthetase 2, mitochondrial |
increases expression |
EXP |
Ouabain results in increased expression of FARS2 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 6:5,249,934...5,771,583
Ensembl chr 6:5,261,044...5,829,192
|
|
G |
FAS |
Fas cell surface death receptor |
increases expression |
EXP |
Ouabain results in increased expression of FAS protein |
CTD |
PMID:31436044 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FASLG |
Fas ligand |
increases expression |
EXP |
Ouabain results in increased expression of FASLG protein |
CTD |
PMID:31436044 |
|
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
FBXO32 |
F-box protein 32 |
multiple interactions |
ISO |
Ouabain affects the reaction [Botulinum Toxins, Type A affects the expression of FBXO32 mRNA] |
CTD |
PMID:21139329 |
|
NCBI chr 8:123,497,889...123,541,206
Ensembl chr 8:123,497,889...123,541,206
|
|
G |
FH |
fumarate hydratase |
affects expression |
EXP |
Ouabain affects the expression of FH protein |
CTD |
PMID:17268060 |
|
NCBI chr 1:241,497,603...241,519,755
Ensembl chr 1:241,497,511...241,519,799
|
|
G |
FKBP7 |
FKBP prolyl isomerase 7 |
increases expression |
EXP |
Ouabain results in increased expression of FKBP7 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 2:178,463,664...178,478,600
Ensembl chr 2:178,463,664...178,478,600
|
|
G |
FN1 |
fibronectin 1 |
decreases expression |
EXP |
Ouabain results in decreased expression of FN1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
GC |
GC vitamin D binding protein |
affects expression |
EXP |
Ouabain affects the expression of GC protein |
CTD |
PMID:17268060 |
|
NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
|
|
G |
GLRB |
glycine receptor beta |
increases expression |
EXP |
Ouabain results in increased expression of GLRB mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 4:157,076,150...157,172,090
Ensembl chr 4:157,076,125...157,172,090
|
|
G |
GRB2 |
growth factor receptor bound protein 2 |
decreases expression |
EXP |
Ouabain results in decreased expression of GRB2 protein |
CTD |
PMID:28795476 |
|
NCBI chr17:75,318,076...75,405,678
Ensembl chr17:75,318,076...75,405,709
|
|
G |
GTPBP6 |
GTP binding protein 6 (putative) |
increases expression |
EXP |
Ouabain results in increased expression of GTPBP6 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr X:304,759...318,796 NCBI chr Y:304,759...318,796
Ensembl chr Y:304,529...318,796 Ensembl chr X:304,529...318,796
|
|
G |
H2AX |
H2A.X variant histone |
increases phosphorylation |
EXP |
Ouabain results in increased phosphorylation of H2AX protein |
CTD |
PMID:31436044 |
|
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
|
|
G |
HEY1 |
hes related family bHLH transcription factor with YRPW motif 1 |
increases expression |
EXP |
Ouabain results in increased expression of HEY1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 8:79,764,010...79,767,767
Ensembl chr 8:79,762,371...79,767,857
|
|
G |
HGF |
hepatocyte growth factor |
multiple interactions |
ISO |
Ouabain inhibits the reaction [HGF protein results in increased uptake of estradiol-17 beta-glucuronide] |
CTD |
PMID:18031729 |
|
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
multiple interactions affects localization increases activity |
EXP |
2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [Ouabain affects the localization of HIF1A protein]; 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [Ouabain results in increased phosphorylation of HIF1A protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Ouabain affects the localization of HIF1A protein]; KN 93 inhibits the reaction [Ouabain affects the localization of HIF1A protein]; KN 93 inhibits the reaction [Ouabain results in increased phosphorylation of HIF1A protein]; Ouabain results in increased phosphorylation of and results in increased expression of HIF1A protein Ouabain results in increased activity of HIF1A protein |
CTD |
PMID:19647009 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
HNRNPA2B1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
affects expression |
EXP |
Ouabain affects the expression of HNRNPA2B1 protein |
CTD |
PMID:17268060 |
|
NCBI chr 7:26,189,927...26,200,746
Ensembl chr 7:26,171,151...26,201,529
|
|
G |
HNRNPDL |
heterogeneous nuclear ribonucleoprotein D like |
decreases expression |
EXP |
Ouabain results in decreased expression of HNRNPDL mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 4:82,422,564...82,430,462
Ensembl chr 4:82,422,565...82,430,462
|
|
G |
HPCAL1 |
hippocalcin like 1 |
affects expression |
EXP |
Ouabain affects the expression of HPCAL1 protein |
CTD |
PMID:17268060 |
|
NCBI chr 2:10,302,904...10,427,604
Ensembl chr 2:10,302,889...10,427,617
|
|
G |
HRG |
histidine rich glycoprotein |
affects expression |
EXP |
Ouabain affects the expression of HRG protein |
CTD |
PMID:17268060 |
|
NCBI chr 3:186,666,014...186,678,234
Ensembl chr 3:186,660,216...186,678,234
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
EXP |
Ouabain results in increased expression of HSPA5 protein |
CTD |
PMID:31436044 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
HSPD1 |
heat shock protein family D (Hsp60) member 1 |
affects expression multiple interactions |
EXP |
Ouabain affects the expression of HSPD1 protein Ouabain inhibits the reaction [HSPD1 protein binds to BAX protein]; Ouabain results in decreased expression of and affects the localization of HSPD1 protein |
CTD |
PMID:17268060 PMID:18247327 |
|
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
|
|
G |
ID2 |
inhibitor of DNA binding 2 |
increases expression |
EXP |
Ouabain results in increased expression of ID2 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
|
|
G |
IL2RA |
interleukin 2 receptor subunit alpha |
decreases expression |
EXP |
Ouabain results in decreased expression of IL2RA mRNA |
CTD |
PMID:7593202 |
|
NCBI chr10:6,010,689...6,062,367
Ensembl chr10:6,010,689...6,062,370
|
|
G |
IL2RB |
interleukin 2 receptor subunit beta |
decreases expression |
EXP |
Ouabain results in decreased expression of IL2RB |
CTD |
PMID:7593202 |
|
NCBI chr22:37,125,838...37,175,118
Ensembl chr22:37,118,666...37,175,118
|
|
G |
IL6 |
interleukin 6 |
increases secretion increases expression |
EXP |
Ouabain results in increased secretion of IL6 protein Ouabain results in increased expression of IL6 mRNA |
CTD |
PMID:33760381 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
IL6R |
interleukin 6 receptor |
increases expression |
EXP |
Ouabain results in increased expression of IL6R mRNA |
CTD |
PMID:33760381 |
|
NCBI chr 1:154,405,343...154,469,450
Ensembl chr 1:154,405,193...154,469,450
|
|
G |
ILK |
integrin linked kinase |
decreases expression |
EXP |
Ouabain results in decreased expression of ILK mRNA |
CTD |
PMID:28795476 |
|
NCBI chr11:6,603,774...6,610,870
Ensembl chr11:6,603,708...6,610,874
|
|
G |
ITGAV |
integrin subunit alpha V |
decreases expression |
EXP |
Ouabain results in decreased expression of ITGAV mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 2:186,590,056...186,680,901
Ensembl chr 2:186,590,010...186,680,901
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression decreases phosphorylation |
EXP |
Ouabain results in decreased expression of JUN mRNA Ouabain results in decreased phosphorylation of JUN protein |
CTD |
PMID:28795476 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
KCND2 |
potassium voltage-gated channel subfamily D member 2 |
increases expression |
EXP ISO |
Ouabain results in increased expression of KCND2 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 7:120,272,908...120,750,337
Ensembl chr 7:120,273,175...120,750,337
|
|
G |
KCNH2 |
potassium voltage-gated channel subfamily H member 2 |
decreases expression decreases activity multiple interactions |
EXP |
Ouabain results in decreased expression of KCNH2 protein modified form Ouabain results in decreased activity of KCNH2 protein Ouabain inhibits the reaction [KCNH2 protein results in increased transport of Thallium] |
CTD |
PMID:19139152 PMID:21158687 |
|
NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
|
|
G |
LEF1 |
lymphoid enhancer binding factor 1 |
decreases expression |
EXP |
Ouabain results in decreased expression of LEF1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 4:108,047,548...108,168,932
Ensembl chr 4:108,047,545...108,168,956
|
|
G |
LGALS1 |
galectin 1 |
affects expression increases expression |
EXP |
Ouabain affects the expression of LGALS1 protein Ouabain results in increased expression of LGALS1 protein |
CTD |
PMID:17268060 PMID:18247327 |
|
NCBI chr22:37,675,636...37,679,802
Ensembl chr22:37,675,636...37,679,802
|
|
G |
LIMK1 |
LIM domain kinase 1 |
decreases expression |
EXP |
Ouabain results in decreased expression of LIMK1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 7:74,083,804...74,122,525
Ensembl chr 7:74,082,933...74,122,525
|
|
G |
LSS |
lanosterol synthase |
increases abundance |
EXP |
LSS protein results in increased abundance of Ouabain |
CTD |
PMID:21106941 |
|
NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
|
|
G |
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
increases expression |
EXP |
Ouabain results in increased expression of MAP2K6 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr17:69,414,697...69,553,865
Ensembl chr17:69,414,697...69,553,865
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions decreases phosphorylation increases phosphorylation |
ISO EXP |
N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in increased phosphorylation of MAPK1 protein] Ouabain results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:19687166 PMID:28795476 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions decreases phosphorylation increases phosphorylation |
ISO EXP |
N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in increased phosphorylation of MAPK3 protein] Ouabain results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:19687166 PMID:28795476 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK7 |
mitogen-activated protein kinase 7 |
multiple interactions |
EXP |
Ouabain inhibits the reaction [palytoxin results in increased phosphorylation of and results in increased activity of MAPK7 protein] |
CTD |
PMID:19716839 |
|
NCBI chr17:19,377,750...19,383,544
Ensembl chr17:19,377,721...19,383,544
|
|
G |
MDH2 |
malate dehydrogenase 2 |
affects expression |
EXP |
Ouabain affects the expression of MDH2 protein |
CTD |
PMID:17268060 |
|
NCBI chr 7:76,048,106...76,067,508
Ensembl chr 7:76,048,051...76,067,508
|
|
G |
MDM2 |
MDM2 proto-oncogene |
multiple interactions |
EXP |
Ouabain results in decreased expression of and results in decreased phosphorylation of MDM2 protein |
CTD |
PMID:31436044 |
|
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
|
|
G |
MGMT |
O-6-methylguanine-DNA methyltransferase |
decreases expression |
EXP |
Ouabain results in decreased expression of MGMT protein |
CTD |
PMID:31436044 |
|
NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983
|
|
G |
MIR29B1 |
microRNA 29b-1 |
multiple interactions decreases expression |
ISO |
MIR29B1 mRNA inhibits the reaction [Ouabain results in increased expression of COL1A1 mRNA] Ouabain results in decreased expression of MIR29B1 mRNA |
CTD |
PMID:26702050 |
|
NCBI chr 7:130,877,459...130,877,539
Ensembl chr 7:130,877,459...130,877,539
|
|
G |
MMP13 |
matrix metallopeptidase 13 |
decreases expression |
EXP |
Ouabain results in decreased expression of MMP13 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
decreases expression multiple interactions |
EXP |
Ouabain results in decreased expression of MMP2 mRNA Ouabain results in decreased expression of and results in decreased activity of MMP2 protein |
CTD |
PMID:28795476 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
decreases expression |
EXP |
Ouabain results in decreased expression of MMP9 mRNA; Ouabain results in decreased expression of MMP9 protein |
CTD |
PMID:28795476 PMID:33760381 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MRAS |
muscle RAS oncogene homolog |
decreases expression |
EXP |
Ouabain results in decreased expression of MRAS mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 3:138,347,648...138,405,535
Ensembl chr 3:138,347,648...138,405,534
|
|
G |
MRTFA |
myocardin related transcription factor A |
decreases expression |
EXP |
Ouabain results in decreased expression of MRTFA mRNA |
CTD |
PMID:28795476 |
|
NCBI chr22:40,410,289...40,636,719
Ensembl chr22:40,410,281...40,636,719
|
|
G |
MYC |
MYC proto-oncogene, bHLH transcription factor |
decreases expression increases expression |
EXP |
Ouabain results in decreased expression of MYC mRNA; Ouabain results in decreased expression of MYC protein Ouabain results in increased expression of MYC protein |
CTD |
PMID:9653513 PMID:21215801 |
|
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
|
|
G |
MYL12A |
myosin light chain 12A |
increases expression |
EXP |
Ouabain results in increased expression of MYL12A protein |
CTD |
PMID:17268060 |
|
NCBI chr18:3,247,482...3,256,237
Ensembl chr18:3,247,481...3,256,236
|
|
G |
MYLK |
myosin light chain kinase |
decreases expression |
EXP |
Ouabain results in decreased expression of MYLK mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 3:123,610,049...123,884,332
Ensembl chr 3:123,610,049...123,884,332
|
|
G |
NECTIN3 |
nectin cell adhesion molecule 3 |
decreases expression |
EXP |
Ouabain results in decreased expression of NECTIN3 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 3:111,071,816...111,194,170
Ensembl chr 3:111,070,071...111,275,563
|
|
G |
NECTIN4 |
nectin cell adhesion molecule 4 |
increases expression |
EXP |
Ouabain results in increased expression of NECTIN4 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 1:161,070,998...161,089,558
Ensembl chr 1:161,070,998...161,089,558
|
|
G |
NEFL |
neurofilament light chain |
decreases expression |
EXP |
Ouabain results in decreased expression of NEFL mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721
|
|
G |
NOS1 |
nitric oxide synthase 1 |
affects expression increases expression |
ISO |
Ouabain affects the expression of NOS1 protein Ouabain results in increased expression of NOS1 protein |
CTD |
PMID:12384489 PMID:15097235 |
|
NCBI chr12:117,208,142...117,361,626
Ensembl chr12:117,208,142...117,452,170
|
|
G |
NOS3 |
nitric oxide synthase 3 |
multiple interactions affects expression increases expression |
ISO |
5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide inhibits the reaction [Ouabain results in increased expression of NOS3 protein] Ouabain affects the expression of NOS3 protein |
CTD |
PMID:12384489 PMID:15477225 |
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
NPC2 |
NPC intracellular cholesterol transporter 2 |
decreases expression |
EXP |
Ouabain results in decreased expression of NPC2 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr14:74,479,935...74,493,512
Ensembl chr14:74,476,192...74,494,177
|
|
G |
NPPA |
natriuretic peptide A |
increases expression multiple interactions |
ISO |
Ouabain results in increased expression of NPPA mRNA N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in increased expression of NPPA mRNA]; Ouabain promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] |
CTD |
PMID:17266992 PMID:19687166 |
|
NCBI chr 1:11,845,709...11,847,783
Ensembl chr 1:11,845,709...11,848,345
|
|
G |
NRAS |
NRAS proto-oncogene, GTPase |
decreases expression |
EXP |
Ouabain results in decreased expression of NRAS mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 1:114,704,469...114,716,771
Ensembl chr 1:114,704,469...114,716,771
|
|
G |
PARK7 |
Parkinsonism associated deglycase |
affects response to substance |
ISO |
PARK7 affects the susceptibility to Ouabain |
CTD |
PMID:16624565 |
|
NCBI chr 1:7,961,711...7,985,505
Ensembl chr 1:7,954,291...7,985,505
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
EXP |
Mitomycin promotes the reaction [Ouabain results in increased cleavage of PARP1 protein]; Ouabain promotes the reaction [Mitomycin results in increased cleavage of PARP1 protein] |
CTD |
PMID:24124520 PMID:31436044 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PCNA |
proliferating cell nuclear antigen |
decreases expression |
EXP |
Ouabain results in decreased expression of PCNA mRNA; Ouabain results in decreased expression of PCNA protein |
CTD |
PMID:20460749 PMID:21215801 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PDCD6 |
programmed cell death 6 |
increases expression |
EXP |
Ouabain results in increased expression of PDCD6 protein |
CTD |
PMID:18247327 |
|
NCBI chr 5:271,646...314,974
Ensembl chr 5:271,621...314,974
|
|
G |
PFDN5 |
prefoldin subunit 5 |
affects expression |
EXP |
Ouabain affects the expression of PFDN5 protein |
CTD |
PMID:17268060 |
|
NCBI chr12:53,295,542...53,299,450
Ensembl chr12:53,295,291...53,299,452
|
|
G |
PFN1 |
profilin 1 |
affects expression decreases expression |
EXP |
Ouabain affects the expression of PFN1 protein Ouabain results in decreased expression of PFN1 protein |
CTD |
PMID:17268060 PMID:18247327 |
|
NCBI chr17:4,945,652...4,948,530
Ensembl chr17:4,945,652...4,949,061
|
|
G |
PLAUR |
plasminogen activator, urokinase receptor |
decreases expression |
EXP |
Ouabain results in decreased expression of PLAUR mRNA |
CTD |
PMID:28795476 |
|
NCBI chr19:43,646,095...43,670,169
Ensembl chr19:43,646,095...43,670,547
|
|
G |
PLCG1 |
phospholipase C gamma 1 |
decreases expression |
EXP |
Ouabain results in decreased expression of PLCG1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr20:41,137,543...41,177,626
Ensembl chr20:41,136,960...41,196,801
|
|
G |
PPT2 |
palmitoyl-protein thioesterase 2 |
decreases expression |
EXP |
Ouabain results in decreased expression of PPT2 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 6:32,153,528...32,163,675
Ensembl chr 6:32,153,441...32,163,678
|
|
G |
PRKDC |
protein kinase, DNA-activated, catalytic subunit |
decreases expression |
EXP |
Ouabain results in decreased expression of PRKDC protein |
CTD |
PMID:31436044 |
|
NCBI chr 8:47,773,111...47,960,136
Ensembl chr 8:47,773,111...47,960,178
|
|
G |
PSMB6 |
proteasome 20S subunit beta 6 |
affects expression |
EXP |
Ouabain affects the expression of PSMB6 protein |
CTD |
PMID:17268060 |
|
NCBI chr17:4,796,164...4,798,495
Ensembl chr17:4,796,144...4,798,502
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
ISO |
[Ouabain results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Nitric Oxide |
CTD |
PMID:18976649 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PTPN2 |
protein tyrosine phosphatase non-receptor type 2 |
decreases expression |
EXP |
Ouabain results in decreased expression of PTPN2 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr18:12,785,478...12,884,237
Ensembl chr18:12,785,478...12,929,643
|
|
G |
RAB11B |
RAB11B, member RAS oncogene family |
increases expression |
EXP |
Ouabain results in increased expression of RAB11B protein |
CTD |
PMID:18247327 |
|
NCBI chr19:8,390,360...8,404,434
Ensembl chr19:8,389,981...8,404,434
|
|
G |
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
decreases expression |
EXP |
Ouabain results in decreased expression of RAF1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 3:12,583,601...12,664,117
Ensembl chr 3:12,582,101...12,664,201
|
|
G |
RASGRF1 |
Ras protein specific guanine nucleotide releasing factor 1 |
decreases expression |
EXP |
Ouabain results in decreased expression of RASGRF1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr15:78,959,906...79,090,780
Ensembl chr15:78,959,906...79,090,780
|
|
G |
RGS2 |
regulator of G protein signaling 2 |
decreases expression |
EXP |
Ouabain results in decreased expression of RGS2 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 1:192,809,039...192,812,275
Ensembl chr 1:192,809,039...192,812,275
|
|
G |
RHOH |
ras homolog family member H |
increases expression |
EXP |
Ouabain results in increased expression of RHOH mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 4:40,191,080...40,246,967
Ensembl chr 4:40,191,011...40,246,967
|
|
G |
ROCK1 |
Rho associated coiled-coil containing protein kinase 1 |
increases cleavage multiple interactions |
EXP |
Ouabain results in increased cleavage of ROCK1 protein benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Ouabain results in increased cleavage of ROCK1 protein] |
CTD |
PMID:20661774 |
|
NCBI chr18:20,946,906...21,111,813
Ensembl chr18:20,944,612...21,111,813
|
|
G |
ROCK2 |
Rho associated coiled-coil containing protein kinase 2 |
multiple interactions increases cleavage |
EXP |
benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [Ouabain results in increased cleavage of ROCK2 protein] |
CTD |
PMID:20661774 |
|
NCBI chr 2:11,179,759...11,345,437
Ensembl chr 2:11,179,759...11,348,330
|
|
G |
RPA3 |
replication protein A3 |
affects expression |
EXP |
Ouabain affects the expression of RPA3 protein |
CTD |
PMID:17268060 |
|
NCBI chr 7:7,636,518...7,718,607
Ensembl chr 7:7,636,518...7,718,607
|
|
G |
RPGRIP1L |
RPGRIP1 like |
decreases expression |
EXP |
Ouabain results in decreased expression of RPGRIP1L mRNA |
CTD |
PMID:16412265 |
|
NCBI chr16:53,598,153...53,703,859
Ensembl chr16:53,598,153...53,703,938
|
|
G |
RPS6KB1 |
ribosomal protein S6 kinase B1 |
affects expression |
ISO |
Ouabain affects the expression of RPS6KB1 mRNA |
CTD |
PMID:28099878 |
|
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
|
|
G |
RYR2 |
ryanodine receptor 2 |
multiple interactions increases response to substance |
ISO |
K201 compound inhibits the reaction [RYR2 mutant form results in increased susceptibility to Ouabain] |
CTD |
PMID:20080988 |
|
NCBI chr 1:237,042,184...237,833,988
Ensembl chr 1:237,042,184...237,833,988
|
|
G |
S100A13 |
S100 calcium binding protein A13 |
affects expression |
EXP |
Ouabain affects the expression of S100A13 protein |
CTD |
PMID:17268060 |
|
NCBI chr 1:153,618,799...153,634,361
Ensembl chr 1:153,618,787...153,631,360
|
|
G |
S100B |
S100 calcium binding protein B |
increases expression |
ISO |
Ouabain results in increased expression of S100B protein |
CTD |
PMID:15581912 |
|
NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208
|
|
G |
SGK1 |
serum/glucocorticoid regulated kinase 1 |
multiple interactions decreases expression |
EXP |
Ouabain inhibits the reaction [SGK1 protein results in increased transport of Potassium] Ouabain results in decreased expression of SGK1 mRNA |
CTD |
PMID:12590200 PMID:28795476 |
|
NCBI chr 6:134,169,256...134,318,112
Ensembl chr 6:134,169,248...134,318,112
|
|
G |
SGK2 |
serum/glucocorticoid regulated kinase 2 |
multiple interactions |
EXP |
Ouabain inhibits the reaction [SGK2 protein results in increased transport of Potassium] |
CTD |
PMID:12590200 |
|
NCBI chr20:43,559,027...43,585,627
Ensembl chr20:43,558,968...43,588,237
|
|
G |
SGK3 |
serum/glucocorticoid regulated kinase family member 3 |
multiple interactions |
EXP |
Ouabain inhibits the reaction [SGK3 protein results in increased transport of Potassium] |
CTD |
PMID:12590200 |
|
NCBI chr 8:66,712,781...66,862,022
Ensembl chr 8:66,712,734...66,862,022
|
|
G |
SHC3 |
SHC adaptor protein 3 |
increases expression |
EXP |
Ouabain results in increased expression of SHC3 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 9:89,005,771...89,178,818
Ensembl chr 9:89,005,771...89,178,818
|
|
G |
SLC16A1 |
solute carrier family 16 member 1 |
multiple interactions |
EXP |
Ouabain inhibits the reaction [SLC16A1 protein results in increased uptake of Lactic Acid] |
CTD |
PMID:15804185 |
|
NCBI chr 1:112,911,847...112,956,196
Ensembl chr 1:112,911,847...112,957,593
|
|
G |
SLC22A12 |
solute carrier family 22 member 12 |
multiple interactions |
ISO |
Ouabain promotes the reaction [SLC22A12 protein results in increased uptake of p-Aminohippuric Acid] |
CTD |
PMID:15284287 |
|
NCBI chr11:64,591,220...64,602,344
Ensembl chr11:64,590,641...64,602,353
|
|
G |
SLC5A5 |
solute carrier family 5 member 5 |
multiple interactions |
EXP |
Ouabain inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide] |
CTD |
PMID:12541134 |
|
NCBI chr19:17,871,945...17,895,174
Ensembl chr19:17,871,945...17,895,174
|
|
G |
SLC5A6 |
solute carrier family 5 member 6 |
multiple interactions |
EXP |
Ouabain inhibits the reaction [SLC5A6 protein results in increased transport of Biotin] |
CTD |
PMID:15561972 |
|
NCBI chr 2:27,199,587...27,212,787
Ensembl chr 2:27,199,587...27,212,958
|
|
G |
SLC8A1 |
solute carrier family 8 member A1 |
affects response to substance increases expression multiple interactions |
ISO |
SLC8A1 affects the susceptibility to Ouabain Ouabain results in increased expression of SLC8A1 protein SLC8A1 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of SLC8A1 protein]; SLC8A1 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of TRPC6 protein]; TRPC6 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of SLC8A1 protein] |
CTD |
PMID:16166162 PMID:19897708 |
|
NCBI chr 2:40,097,270...40,512,435
Ensembl chr 2:40,097,270...40,611,053
|
|
G |
SLC9A1 |
solute carrier family 9 member A1 |
multiple interactions increases expression |
ISO |
N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in increased expression of SLC9A1 mRNA] |
CTD |
PMID:19687166 |
|
NCBI chr 1:27,098,809...27,155,125
Ensembl chr 1:27,098,809...27,166,981
|
|
G |
SMAD4 |
SMAD family member 4 |
decreases expression |
EXP |
Ouabain results in decreased expression of SMAD4 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr18:51,030,213...51,085,042
Ensembl chr18:51,028,528...51,085,045
|
|
G |
SNAI1 |
snail family transcriptional repressor 1 |
decreases expression |
EXP |
Ouabain results in decreased expression of SNAI1 mRNA |
CTD |
PMID:33760381 |
|
NCBI chr20:49,982,980...49,988,886
Ensembl chr20:49,982,980...49,988,886
|
|
G |
SOS1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
decreases expression |
EXP |
Ouabain results in decreased expression of SOS1 protein |
CTD |
PMID:28795476 |
|
NCBI chr 2:38,981,549...39,124,868
Ensembl chr 2:38,962,206...39,124,345
|
|
G |
SOS2 |
SOS Ras/Rho guanine nucleotide exchange factor 2 |
decreases expression |
EXP |
Ouabain results in decreased expression of SOS2 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr14:50,117,130...50,231,882
Ensembl chr14:50,117,130...50,231,578
|
|
G |
SPHK1 |
sphingosine kinase 1 |
decreases expression |
EXP |
Ouabain results in decreased expression of SPHK1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr17:76,383,204...76,387,855
Ensembl chr17:76,376,584...76,387,860
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
decreases expression |
EXP |
Ouabain results in decreased expression of TGFB1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TGFB2 |
transforming growth factor beta 2 |
decreases expression |
EXP |
Ouabain results in decreased expression of TGFB2 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 1:218,345,336...218,444,619
Ensembl chr 1:218,345,336...218,444,619
|
|
G |
TGFB3 |
transforming growth factor beta 3 |
decreases expression |
EXP |
Ouabain results in decreased expression of TGFB3 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr14:75,958,097...75,983,011
Ensembl chr14:75,958,097...75,983,011
|
|
G |
TGFBR3 |
transforming growth factor beta receptor 3 |
increases expression |
EXP |
Ouabain results in increased expression of TGFBR3 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 1:91,680,343...91,906,002
Ensembl chr 1:91,680,343...91,906,335
|
|
G |
TLN1 |
talin 1 |
decreases expression |
EXP |
Ouabain results in decreased expression of TLN1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 9:35,696,948...35,732,195
Ensembl chr 9:35,696,948...35,732,195
|
|
G |
TLN2 |
talin 2 |
decreases expression |
EXP |
Ouabain results in decreased expression of TLN2 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr15:62,390,550...62,844,631
Ensembl chr15:62,390,526...62,844,631
|
|
G |
TNFRSF10A |
TNF receptor superfamily member 10a |
increases expression |
EXP |
Ouabain results in increased expression of TNFRSF10A protein |
CTD |
PMID:31436044 |
|
NCBI chr 8:23,190,452...23,225,102
Ensembl chr 8:23,190,452...23,225,102
|
|
G |
TNFRSF10B |
TNF receptor superfamily member 10b |
increases expression |
EXP |
Ouabain results in increased expression of TNFRSF10B protein |
CTD |
PMID:31436044 |
|
NCBI chr 8:23,020,133...23,069,031
Ensembl chr 8:23,020,133...23,069,031
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions |
EXP |
Ouabain results in decreased expression of and results in increased phosphorylation of TP53 protein |
CTD |
PMID:31436044 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
TPI1 |
triosephosphate isomerase 1 |
affects expression |
EXP |
Ouabain affects the expression of TPI1 protein |
CTD |
PMID:17268060 |
|
NCBI chr12:6,867,420...6,870,948
Ensembl chr12:6,867,119...6,870,948
|
|
G |
TPT1 |
tumor protein, translationally-controlled 1 |
affects expression |
EXP |
Ouabain affects the expression of TPT1 protein |
CTD |
PMID:17268060 |
|
NCBI chr13:45,333,471...45,341,183
Ensembl chr13:45,333,471...45,341,284
|
|
G |
TRIM63 |
tripartite motif containing 63 |
multiple interactions |
ISO |
[Ouabain co-treated with Botulinum Toxins, Type A] affects the expression of TRIM63 mRNA |
CTD |
PMID:21139329 |
|
NCBI chr 1:26,051,301...26,067,630
Ensembl chr 1:26,051,301...26,068,436
|
|
G |
TRPC1 |
transient receptor potential cation channel subfamily C member 1 |
increases expression |
ISO |
Ouabain results in increased expression of TRPC1 protein |
CTD |
PMID:19897708 |
|
NCBI chr 3:142,724,034...142,807,888
Ensembl chr 3:142,724,034...142,807,888
|
|
G |
TRPC6 |
transient receptor potential cation channel subfamily C member 6 |
increases expression multiple interactions |
ISO |
Ouabain results in increased expression of TRPC6 protein SLC8A1 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of TRPC6 protein]; TRPC6 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of SLC8A1 protein]; TRPC6 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of TRPC6 protein] |
CTD |
PMID:19897708 |
|
NCBI chr11:101,451,564...101,584,007
Ensembl chr11:101,451,564...101,872,562
|
|
G |
TWIST1 |
twist family bHLH transcription factor 1 |
increases expression |
EXP |
Ouabain results in increased expression of TWIST1 mRNA |
CTD |
PMID:33760381 |
|
NCBI chr 7:19,113,047...19,117,636
Ensembl chr 7:19,020,991...19,117,636
|
|
G |
TXN |
thioredoxin |
affects expression |
EXP |
Ouabain affects the expression of TXN protein |
CTD |
PMID:17268060 |
|
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
|
|
G |
VIM |
vimentin |
decreases expression |
EXP |
Ouabain results in decreased expression of VIM mRNA |
CTD |
PMID:33760381 |
|
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
|
|
G |
ZFHX3 |
zinc finger homeobox 3 |
decreases expression |
EXP |
Ouabain results in decreased expression of ZFHX3 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr16:72,782,885...73,891,930
Ensembl chr16:72,782,885...73,891,871
|
|